Volume 96, Issue 4

Search all International Journal of Hematology articles

October 2012

Including PIH Articles on Epigenetics of Hematopoiesis and hHematopoietic Malignancies

Issue Editor:

Atsushi Iwama

20 articles in this issue

Primary intraocular large B cell lymphoma with plasmacytic differentiation
Tohru Inaba
Kenji Nagata
Kazuichi Maruyama
Images in Hematology 11 September 2012 Pages: 399 - 400
Acquired ichthyosis as a presenting finding of Hodgkin’s lymphoma
Timur Selcuk Akpinar
Abdullah Ozkok
Bulent Saka
Images in Hematology 16 September 2012 Pages: 401 - 402
Guest editorial: Epigenetics of hematopoiesis and hematological malignancies
Atsushi Iwama
Progress in Hematology 27 September 2012 Pages: 403 - 404
Epigenetic regulation of hematopoiesis
Goro Sashida
Atsushi Iwama
Progress in Hematology 29 September 2012 Pages: 405 - 412
Epigenetic alterations in hematopoietic malignancies
Young Rock Chung
Emma Schatoff
Omar Abdel-Wahab
Progress in Hematology 27 September 2012 Pages: 413 - 427
Disordered epigenetic regulation in MLL-related leukemia
Yue Zhang
Aili Chen
Gang Huang
Progress in Hematology 29 September 2012 Pages: 428 - 437
Splicing factor mutations in myelodysplasia
Seishi Ogawa
Progress in Hematology 05 October 2012 Pages: 438 - 442
Clonal expansion of Epstein–Barr virus (EBV)-infected γδ T cells in patients with chronic active EBV disease and hydroa vacciniforme-like eruptions
Taizo Wada
Akiko Toga
Akihiro Yachie
Original Article 12 August 2012 Pages: 443 - 449
Polymorphisms in XPC provide prognostic information in acute myeloid leukemia
Peipei Xu
Baoan Chen
Zuhong Lu
Original Article 12 September 2012 Pages: 450 - 460
Elevated serum granulysin and its clinical relevance in mature NK-cell neoplasms
Nodoka Sekiguchi
Naoko Asano
Fumihiro Ishida
Original Article 14 August 2012 Pages: 461 - 468
High WT1 mRNA expression after induction chemotherapy and FLT3-ITD have prognostic impact in pediatric acute myeloid leukemia: a study of the Japanese Childhood AML Cooperative Study Group
Akira Shimada
Tomohiko Taki
Yasuhide Hayashi
Original Article 23 August 2012 Pages: 469 - 476
Post-transplant consolidation therapy using thalidomide alone for the patients with multiple myeloma: a feasibility study in Japanese population
Tomoki Ueda
Rioko Iino
Yutaka Hattori
Original Article 05 September 2012 Pages: 477 - 484
Phase 1 trial of gemtuzumab ozogamicin in combination with enocitabine and daunorubicin for elderly patients with relapsed or refractory acute myeloid leukemia: Japan Adult Leukemia Study Group (JALSG)-GML208 study
Yoshikazu Ito
Atsushi Wakita
Tomoki Naoe
Original Article 06 September 2012 Pages: 485 - 491
Identification of unbalanced genome copy number abnormalities in patients with multiple myeloma by single-nucleotide polymorphism genotyping microarray analysis
Yuhei Kamada
Mamiko Sakata-Yanagimoto
Shigeru Chiba
Original Article 13 September 2012 Pages: 492 - 500
Occurrence of lymphoplasmacytic lymphoma 6 years after amelioration of primary cold agglutinin disease by rituximab therapy
Hiroaki Tanaka
Shinichiro Hashimoto
Chiaki Nakaseko
Case Report 11 August 2012 Pages: 501 - 505
Short- and long-term effects of rituximab for the treatment of thrombotic thrombocytopenic purpura: four case reports
Futoshi Iioka
Daiki Shimomura
Hitoshi Ohno
Case Report 10 August 2012 Pages: 506 - 512
A rare case of intracerebral hemorrhage complicating heparin-induced thrombocytopenia with thrombosis: a clinical dilemma ameliorated by novel use of plasmapheresis
Nay Min Tun
Zaw Min Bo
Gina M. Villani
Case Report 15 August 2012 Pages: 513 - 515
Severe hepatitis associated with varicella zoster virus infection in a patient with diffuse large B cell lymphoma treated with rituximab-CHOP chemotherapy
Akinao Okamoto
Akihiro Abe
Nobuhiko Emi
Case Report 18 August 2012 Pages: 516 - 520
Delayed initiation of front-line imatinib therapy predicts for poor response to nilotinib as second-line treatment of imatinib-resistant or intolerant CML: single center report of the ENACT trial in Lebanon
Zaher K. Otrock
Rami A. Mahfouz
Miguel R. Abboud
Letter to the Editor 09 September 2012 Pages: 521 - 524
Injection site reaction after subcutaneous administration of bortezomib in Japanese patients with multiple myeloma
Tomohiko Kamimura
Toshihiro Miyamoto
Koichi Akashi
Letter to the Editor 08 September 2012 Pages: 525 - 527

Volume 96, Issue 4

Primary intraocular large B cell lymphoma with plasmacytic differentiation

Acquired ichthyosis as a presenting finding of Hodgkin’s lymphoma

Guest editorial: Epigenetics of hematopoiesis and hematological malignancies

Epigenetic regulation of hematopoiesis

Epigenetic alterations in hematopoietic malignancies

Disordered epigenetic regulation in MLL-related leukemia

Splicing factor mutations in myelodysplasia

Clonal expansion of Epstein–Barr virus (EBV)-infected γδ T cells in patients with chronic active EBV disease and hydroa vacciniforme-like eruptions

Polymorphisms in XPC provide prognostic information in acute myeloid leukemia

Elevated serum granulysin and its clinical relevance in mature NK-cell neoplasms

High WT1 mRNA expression after induction chemotherapy and FLT3-ITD have prognostic impact in pediatric acute myeloid leukemia: a study of the Japanese Childhood AML Cooperative Study Group

Post-transplant consolidation therapy using thalidomide alone for the patients with multiple myeloma: a feasibility study in Japanese population

Phase 1 trial of gemtuzumab ozogamicin in combination with enocitabine and daunorubicin for elderly patients with relapsed or refractory acute myeloid leukemia: Japan Adult Leukemia Study Group (JALSG)-GML208 study

Identification of unbalanced genome copy number abnormalities in patients with multiple myeloma by single-nucleotide polymorphism genotyping microarray analysis

Occurrence of lymphoplasmacytic lymphoma 6 years after amelioration of primary cold agglutinin disease by rituximab therapy

Short- and long-term effects of rituximab for the treatment of thrombotic thrombocytopenic purpura: four case reports

A rare case of intracerebral hemorrhage complicating heparin-induced thrombocytopenia with thrombosis: a clinical dilemma ameliorated by novel use of plasmapheresis

Severe hepatitis associated with varicella zoster virus infection in a patient with diffuse large B cell lymphoma treated with rituximab-CHOP chemotherapy

Delayed initiation of front-line imatinib therapy predicts for poor response to nilotinib as second-line treatment of imatinib-resistant or intolerant CML: single center report of the ENACT trial in Lebanon

Injection site reaction after subcutaneous administration of bortezomib in Japanese patients with multiple myeloma

Navigation